Smart Money Alert
Senores Pharmaceuticals Limited
IncreasedSAST
SENORESPharmaceuticalsMarket Cap₹6K Cr
Value
₹95.01 Cr
Shares
11,70,000
Price
₹812
Stake
63.16%
5
5 promoters
Promoter
The move
Five promoters of Senores Pharmaceuticals acquired 11.7 lakh shares for ₹95.01 Cr at ₹812.00 apiece, bringing the promoter group's total stake in the company to 63.16%.
About Senores Pharmaceuticals Limited
Visit stock A pharmaceutical manufacturer that produces complex generic medicines certified by global regulatory authorities including the FDA and WHO. Incorporated in 2015, the company focuses on developing and supplying affordable, high-quality pharmaceutical formulations to domestic and international markets. Its operations center on manufacturing specialized generics that address critical therapeutic areas while maintaining stringent international quality standards and compliance requirements.
Get the next move the moment it happens.
Follow the investors and Senores Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
ICICI Prudential Mutual FundExited
ICICI Prudential Mutual Fund, which previously held 1.37 percent of Senores Pharmaceuticals Limited, has dropped off the company's disclosed shareholder list, indicating either a complete exit or a reduction below the 1 percent reporting threshold.
20 Jul 2026
Read more Aditya Birla Sun Life InsuranceDecreased
Aditya Birla Sun Life Insurance reduced its stake in Senores Pharmaceuticals from 2.96% to 1.62% by selling 617,002 shares. The value of shares sold is ₹86.68 Cr at ₹1405.10 apiece.
20 Jul 2026
Read more Astorne CapitalIncreased
Astorne Capital increased its stake in Senores Pharmaceuticals from 1.53% (705,346 shares) to 1.95% (897,350 shares), acquiring an additional 192,004 shares. The value of its increased holding is ₹12.93 Cr based on Senores Pharmaceuticals' share price of ₹1405.10.
20 Jul 2026
Read more HSBC Mutual FundIncreased
HSBC Mutual Fund increased its stake in Senores Pharmaceuticals Limited from 2.29% to 3.44% by acquiring 527,314 additional shares. This change in holding is worth ₹74.1 Cr at the current share price of ₹1405.10.
20 Jul 2026
Read more Mahindra Manulife Mutual FundDecreased
Mahindra Manulife Mutual Fund decreased its stake in Senores Pharmaceuticals Limited from 1.40% to 1.14%, selling 123,337 shares for ₹17.34 Cr at ₹1405.10 apiece.
20 Jul 2026
Read more